OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Unknown
(3)
Publication Date
Release Date
2026
(1)
2019
(1)
2017
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study.
Not available
S-EPMC5215651
|
biostudies-literature
Cite
Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China.
Not available
S-EPMC6817518
|
biostudies-literature
Cite
A benchmark of expert-level academic questions to assess AI capabilities.
Not available
S-EPMC12851929
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
